From the Journals

NASH rapidly overtaking hepatitis C as cause of liver cancer


 

FROM THE JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY


“Histologically, NASH shares characteristics with alcoholic liver disease, primarily proinflammatory fat accumulation in parenchymal cells, [and] key players in NASH progression to HCC are suggested to include genetic modifications, proinflammatory high-fat and/or high-fructose diets, and oxidative and endoplasmic cellular stresses,” they wrote. “In HCV progression to HCC, the presence of the HCV core protein may induce HCC without the prerequisite load of genetic errors normally required for cancer development, skipping or accelerating some of the classic steps of cancer induction.”

The authors did note that their model represented a base scenario that assumed the environmental and genetic factors driving NASH would continue along the path of current trends.

“Therefore, the possibility exists that our models underestimate the response of the medical community in addressing the rising nonalcoholic fatty liver disease/NASH epidemic.”

No funding sources or conflicts of interest were declared.

SOURCE: Ahmed O et al. J Clin Exp Hepatology. 2018 Feb 24. doi: 10.1016/j.jceh.2018.02.006.

Pages

Recommended Reading

HCV/HIV-coinfected teens rapidly progress to advanced liver disease
HCV Hub
Hepatitis C is a pediatric disease now
HCV Hub
Liver cancer risk lower after sustained response to DAAs
HCV Hub
FDA approves new treatment for adults with HCV
HCV Hub
Biophysical properties of HCV evolve over course of infection
HCV Hub
Study supports routine rapid HCV testing for at-risk youth
HCV Hub
Hep C screening falling short in neonatal abstinence syndrome infants
HCV Hub
Eradicating HCV significantly improved liver stiffness in meta-analysis
HCV Hub
Model validates use of HCV+ livers for transplant
HCV Hub
Baby boomers are the hepatitis C generation
HCV Hub